NCT03674047 2025-11-10
Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT)
Massachusetts General Hospital
Phase 2 Active not recruiting
Clinical Trials
7 trialsNCT03609177 2025-10-21
ACP-PEACE
Dana-Farber Cancer Institute
Phase NA Completed
NCT03967379 2025-02-04
Multimodal Mobile Intervention Application (App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors
Massachusetts General Hospital
Phase NA Completed
NCT03638453 2024-09-19
Pilot Feasibility of the Pediatric Cancer Resource Equity (PediCARE) Intervention
Dana-Farber Cancer Institute
Phase NA Completed
NCT03736746 2022-04-25
Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals
Dana-Farber Cancer Institute
Phase NA Completed
NCT03721926 2022-04-07
A Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer
Massachusetts General Hospital
Phase NA Completed
NCT03752268 2021-05-21
Development of an Intervention to Enhance Cancer Pain Management
Massachusetts General Hospital
Phase NA Unknown